Functional recovery in acute traumatic spinal cord injury after transplantation of human umbilical cord mesenchymal stem cells

Critical Care Medicine

Volumn 38, Issue 11, 2010, Pages 2181-2189

  Hu, Sheng Li ^a   Luo, Hai Shui ^a   Li, Jiang Tao ^a   Xia, Yong Zhi ^a   Li, Lan ^a   Zhang, Li Jun ^a   Meng, Hui ^a   Cui, Gao Yu ^a   Chen, Zhi ^a   Wu, Nan ^a   Lin, Jiang Kai ^a   Zhu, Gang ^a   Feng, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Functional recovery; mesenchymal stem cells; spinal cord injury; transplantation; umbilical cord

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIN 3; NERVE GROWTH FACTOR;

ACUTE TRAUMATIC SPINAL CORD INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN FUNCTION; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GROWTH CONE; HINDLIMB; HUMAN; HUMAN CELL; HUMAN UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; MOTOR PERFORMANCE; NERVE FIBER REGENERATION; NEUROFILAMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SPINAL CORD INJURY; SPRAGUE DAWLEY RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; METHODOLOGY; NERVE REGENERATION; PHYSIOLOGY; SPINAL CORD; UMBILICAL CORD; XENOGRAFT;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOCOMOTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NERVE GROWTH FACTORS; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD; SPINAL CORD INJURIES; TRANSPLANTATION, HETEROLOGOUS; UMBILICAL CORD;

EID: 78049415890     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181f17c0e     Document Type: Article

References (56)

1. Lim P A C, Tow AM: Recovery and regeneration after spinal cord injury: A review and summary of recent literature. Ann Acad Med Singapore 2007;36:49-57
2. Willerth SM, Sakiyama-Elbert SE: Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev 2008;60:263-276
3. Keirstead HS, Nistor G, Bernal G, et al: Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005;25:4694-4705
4. Hofstetter CP, Schwarz EJ, Hess D, et al: Marrow stromal cells from guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci U S A 2002;99:2199-2204
5. Karimi-Abdolrezaee S, Eftekharpour E, Wang J, et al: Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. JNeurosci 2006;26:3377-3389
6. Civin CI: Commitment to biomedical research: Clearing unnecessary impediments to progress. Stem Cells 2002;20:482-484
7. Freed CR: Will embryonic stem cells be a useful source of dopamine neurons for transplant into patients with Parkinson's disease? Proc Natl Acad Sci U S A 2002;99:1755-1757
8. Rao MS, Mattson MP: Stem cells and aging: Expanding the possibilities. Mech Ageing Dev 2001;122:713-734
9. Romanov YA, Svintsitskaya VA, Smirnov VN: Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 2003;21:105-110
10. Wright LS, Prowse KR, Wallace K, et al: Human progenitor cells isolated from the developing cortex undergo decreased neurogenesis and eventual senescence following expansion in vitro. Exp Cell Res 2006;312:2107-2120
11. Marcus AJ, Coyne TM, Rauch J, et al: Isolation, characterization, and differentiation of stem cells derived from the rat amniotic membrane. Differentiation 2008;76:130-144
12. De Coppi P, Bartsch G Jr., Siddiqui MM, et al: Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-106
13. Lee OK, Kuo TK, Chen WM, et al: Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675
14. Lu LL, Liu YJ, Yang SG, et al: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesissupportive function and other potentials. Haematologica 2006;91:1017-1026
15. Secco M, Zucconi E, Vieira NM, et al: Multipotent stem cells from umbilical cord: Cord is richer than blood! Stem Cells 2008;26:146-150
16. Mitchell KE, Weiss ML, Mitchell BM, et al: Matrix cells from Wharton's jelly form neurons and glia. Stem Cells 2003;21:50-60
17. Troyer DL, Weiss ML: Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells 2008;26:591-599
18. Weiss ML, Anderson C, Medicetty S, et al: Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008;26:2865-2874
19. Karahuseyinoglu S, Cinar O, Kilic E, et al: Biology of the stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 2007;25:319-331
20. Sarugaser R, Lickorish D, Baksh D, et al: Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 2005;23:220-229
21. Conconi MT, Burra P, Di Liddo R, et al: CD105 (+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential. Int J Mol Med 2006;18:1089-1096
22. Wang HS, Hung SC, Peng ST, et al: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells 2004;22:1330-1337
23. Chang SA, Lee EJ, Kang HJ, et al: Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: Effect of acute myocardial infarction on stem cell differentiation. Stem Cells 2008;26:1901-1912
24. Wu KH, Zhou B, Lu SH, et al: In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem 2007;100:608-616
25. Fu YS, Shih YT, Cheng YC, et al: Transformation of human umbilical mesenchymal cells into neurons in vitro. J Biomed Sci 2004;11:652-660
26. Ma L, Feng XY, Cui BL, et al: Human umbilical cord Wharton's Jelly-derived mesenchymal stem cells differentiation into nerve-like cells. Chin Med J (Engl) 2005;118:1987-1993
27. Fu YS, Cheng YC, Lin MY, et al: Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: Potential therapeutic application for parkinsonism. Stem Cells 2006;24:115-124
28. Hu SL, Zhang JQ, Hu X, et al: In vitro labeling of human umbilical cord mesenchymal stem cells with superparamagnetic iron oxide nanoparticles. J Cell Biochem 2009;108:529-535
29. Wamil AW, Wamil BD, Hellerqvist CG: CM101-mediated recovery of walking ability in adult mice paralyzed by spinal cord injury. Proc Natl Acad Sci U S A 1998;95:13188-13193
30. Basso DM, Beattie MS, Bresnahan JC: Graded histological and locomotor outcomes after spinal cord contusion using the NYU weightdrop device versus transection. Exp Neurol 1996;139:244-256
31. Zhang SC, Wernig M, Duncan ID, et al: In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat Biotechnol 2001;19:1129-1133
32. Kadner A, Zund G, Maurus C, et al: Human umbilical cord cells for cardiovascular tissue engineering: A comparative study. EurJCardiothorac Surg 2004;25:635-641
33. Jang YK, Jung DH, Jung MH, et al: Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol 2006;85:212-225
34. Gao L, Chen X, Zhang X, et al: Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro. Blood Cells Mol Dis 2006;36:322-328
35. Baksh D, Yao R, Tuan RS: Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 2007;25:1384-1392
36. Kim JW, Kim SY, Park SY, et al: Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol 2004;83:733-738
37. Panepucci RA, Siufi JL, Silva WA Jr, et al: Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004;22:1263-1278
38. Kaltz N, Funari A, Hippauf S, et al: In vivo osteoprogenitor potency of human stromal cells from different tissues does not correlate with expression of POU5F1 or its pseudogenes. Stem Cells 2008;26:2419-2424
39. Weiss ML, Medicetty S, Bledsoe AR, et al: Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006;24:781-792
40. + umbilical cord matrix cells. Stem Cells 2007;25:98-106
41. Zhang ZY, Teoh SH, Chong MS, et al: Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells 2009;27:126-137
42. Cao FJ, Feng SQ: Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury. Chin Med J (Engl) 2009;122:225-231
43. Bailey MM, Wang L, Bode CJ, et al: A comparison of human umbilical cord matrix stem cells and temporomandibular joint condylar chondrocytes for tissue engineering temporomandibular joint condylar cartilage. Tissue Eng 2007;13:2003-2010
44. Ding DC, Shyu WC, Chiang MF, et al: Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis 2007;27:339-353
45. Lund RD, Wang S, Lu B, et al: Cells isolated from umbilical cord tissue rescue photoreceptors and visual functions in a rodent model of retinal disease. Stem Cells 2007;25:602-611
46. Coutts M, Keirstead HS: Stem cells for the treatment of spinal cord injury. Exp Neurol 2008;209:368-377
47. Cummings BJ, Uchida N, Tamaki SJ, et al: Human neural stem cells differentiate and promote locomotor recovery in spinal cordinjured mice. Proc Natl Acad Sci U S A 2005;102:14069-14074
48. Yang CC, Shih YH, Ko MH, et al: Transplantation of human umbilical esenchymal stem cells from Wharton's Jelly after complete transection of the rat spinal cord. PLoS ONE 2008;3: e3336
49. Koh SH, Kim KS, Choi MR, et al: Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats. Brain Res 2008;1229:233-248
50. Rooney GE, McMahon SS, Ritter T, et al: Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cells. Tissue Eng Part A 2009;15:3049-3059
51. Xu XM, Guenard V, Kleitman N, et al: A combination of BDNF and NT-3 promotes supraspinal axonal regeneration into Schwann cell grafts in adult rat thoracic spinal cord. Exp Neurol 1995;134:261-272
52. Tuszynski MH, Grill R, Jones LL, et al: NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection. Exp Neurol 2003;181:47-56
53. Cao Q, Xu XM, Devries WH, et al: Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005;25:6947-6957
54. Fitch MT, Silver J: CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol 2008;209:294-301
55. Fok-Seang J, Smith-Thomas LC, Meiners S, et al: An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res 1995;689:207-223
56. Bradbury EJ, Moon LD, Popat RJ, et al: Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002;416:636-640